Melanoma Cancer Market, Global Outlook and Forecast 2022-2028

March 2022 | 64 pages | ID: ME9ECEA723A6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Melanoma Cancer in Global, including the following market information:

Global Melanoma Cancer Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Melanoma Cancer market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Non-invasive melanoma Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Melanoma Cancer include AB Sciences, Incyte, Merck, Novartis, Pierre Fabre, Amgen, AstraZeneca, Bristol-Myers Squibb and Daiichi Sankyo. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Melanoma Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Melanoma Cancer Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Melanoma Cancer Market Segment Percentages, by Type, 2021 (%)

• Non-invasive melanoma
• Invasive melanoma

Global Melanoma Cancer Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Melanoma Cancer Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Cancer Research Centers

Global Melanoma Cancer Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Melanoma Cancer Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Melanoma Cancer revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Melanoma Cancer revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AB Sciences
• Incyte
• Merck
• Novartis
• Pierre Fabre
• Amgen
• AstraZeneca
• Bristol-Myers Squibb
• Daiichi Sankyo

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Melanoma Cancer Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Melanoma Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL MELANOMA CANCER OVERALL MARKET SIZE

2.1 Global Melanoma Cancer Market Size: 2021 VS 2028
2.2 Global Melanoma Cancer Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Melanoma Cancer Players in Global Market
3.2 Top Global Melanoma Cancer Companies Ranked by Revenue
3.3 Global Melanoma Cancer Revenue by Companies
3.4 Top 3 and Top 5 Melanoma Cancer Companies in Global Market, by Revenue in 2021
3.5 Global Companies Melanoma Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Melanoma Cancer Players in Global Market
  3.6.1 List of Global Tier 1 Melanoma Cancer Companies
  3.6.2 List of Global Tier 2 and Tier 3 Melanoma Cancer Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Melanoma Cancer Market Size Markets, 2021 & 2028
  4.1.2 Non-invasive melanoma
  4.1.3 Invasive melanoma
4.2 By Type - Global Melanoma Cancer Revenue & Forecasts
  4.2.1 By Type - Global Melanoma Cancer Revenue, 2017-2022
  4.2.2 By Type - Global Melanoma Cancer Revenue, 2023-2028
  4.2.3 By Type - Global Melanoma Cancer Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Melanoma Cancer Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Cancer Research Centers
5.2 By Application - Global Melanoma Cancer Revenue & Forecasts
  5.2.1 By Application - Global Melanoma Cancer Revenue, 2017-2022
  5.2.2 By Application - Global Melanoma Cancer Revenue, 2023-2028
  5.2.3 By Application - Global Melanoma Cancer Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Melanoma Cancer Market Size, 2021 & 2028
6.2 By Region - Global Melanoma Cancer Revenue & Forecasts
  6.2.1 By Region - Global Melanoma Cancer Revenue, 2017-2022
  6.2.2 By Region - Global Melanoma Cancer Revenue, 2023-2028
  6.2.3 By Region - Global Melanoma Cancer Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Melanoma Cancer Revenue, 2017-2028
  6.3.2 US Melanoma Cancer Market Size, 2017-2028
  6.3.3 Canada Melanoma Cancer Market Size, 2017-2028
  6.3.4 Mexico Melanoma Cancer Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Melanoma Cancer Revenue, 2017-2028
  6.4.2 Germany Melanoma Cancer Market Size, 2017-2028
  6.4.3 France Melanoma Cancer Market Size, 2017-2028
  6.4.4 U.K. Melanoma Cancer Market Size, 2017-2028
  6.4.5 Italy Melanoma Cancer Market Size, 2017-2028
  6.4.6 Russia Melanoma Cancer Market Size, 2017-2028
  6.4.7 Nordic Countries Melanoma Cancer Market Size, 2017-2028
  6.4.8 Benelux Melanoma Cancer Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Melanoma Cancer Revenue, 2017-2028
  6.5.2 China Melanoma Cancer Market Size, 2017-2028
  6.5.3 Japan Melanoma Cancer Market Size, 2017-2028
  6.5.4 South Korea Melanoma Cancer Market Size, 2017-2028
  6.5.5 Southeast Asia Melanoma Cancer Market Size, 2017-2028
  6.5.6 India Melanoma Cancer Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Melanoma Cancer Revenue, 2017-2028
  6.6.2 Brazil Melanoma Cancer Market Size, 2017-2028
  6.6.3 Argentina Melanoma Cancer Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Melanoma Cancer Revenue, 2017-2028
  6.7.2 Turkey Melanoma Cancer Market Size, 2017-2028
  6.7.3 Israel Melanoma Cancer Market Size, 2017-2028
  6.7.4 Saudi Arabia Melanoma Cancer Market Size, 2017-2028
  6.7.5 UAE Melanoma Cancer Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AB Sciences
  7.1.1 AB Sciences Corporate Summary
  7.1.2 AB Sciences Business Overview
  7.1.3 AB Sciences Melanoma Cancer Major Product Offerings
  7.1.4 AB Sciences Melanoma Cancer Revenue in Global Market (2017-2022)
  7.1.5 AB Sciences Key News
7.2 Incyte
  7.2.1 Incyte Corporate Summary
  7.2.2 Incyte Business Overview
  7.2.3 Incyte Melanoma Cancer Major Product Offerings
  7.2.4 Incyte Melanoma Cancer Revenue in Global Market (2017-2022)
  7.2.5 Incyte Key News
7.3 Merck
  7.3.1 Merck Corporate Summary
  7.3.2 Merck Business Overview
  7.3.3 Merck Melanoma Cancer Major Product Offerings
  7.3.4 Merck Melanoma Cancer Revenue in Global Market (2017-2022)
  7.3.5 Merck Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Melanoma Cancer Major Product Offerings
  7.4.4 Novartis Melanoma Cancer Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Pierre Fabre
  7.5.1 Pierre Fabre Corporate Summary
  7.5.2 Pierre Fabre Business Overview
  7.5.3 Pierre Fabre Melanoma Cancer Major Product Offerings
  7.5.4 Pierre Fabre Melanoma Cancer Revenue in Global Market (2017-2022)
  7.5.5 Pierre Fabre Key News
7.6 Amgen
  7.6.1 Amgen Corporate Summary
  7.6.2 Amgen Business Overview
  7.6.3 Amgen Melanoma Cancer Major Product Offerings
  7.6.4 Amgen Melanoma Cancer Revenue in Global Market (2017-2022)
  7.6.5 Amgen Key News
7.7 AstraZeneca
  7.7.1 AstraZeneca Corporate Summary
  7.7.2 AstraZeneca Business Overview
  7.7.3 AstraZeneca Melanoma Cancer Major Product Offerings
  7.7.4 AstraZeneca Melanoma Cancer Revenue in Global Market (2017-2022)
  7.7.5 AstraZeneca Key News
7.8 Bristol-Myers Squibb
  7.8.1 Bristol-Myers Squibb Corporate Summary
  7.8.2 Bristol-Myers Squibb Business Overview
  7.8.3 Bristol-Myers Squibb Melanoma Cancer Major Product Offerings
  7.8.4 Bristol-Myers Squibb Melanoma Cancer Revenue in Global Market (2017-2022)
  7.8.5 Bristol-Myers Squibb Key News
7.9 Daiichi Sankyo
  7.9.1 Daiichi Sankyo Corporate Summary
  7.9.2 Daiichi Sankyo Business Overview
  7.9.3 Daiichi Sankyo Melanoma Cancer Major Product Offerings
  7.9.4 Daiichi Sankyo Melanoma Cancer Revenue in Global Market (2017-2022)
  7.9.5 Daiichi Sankyo Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Melanoma Cancer Market Opportunities & Trends in Global Market
Table 2. Melanoma Cancer Market Drivers in Global Market
Table 3. Melanoma Cancer Market Restraints in Global Market
Table 4. Key Players of Melanoma Cancer in Global Market
Table 5. Top Melanoma Cancer Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Melanoma Cancer Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Melanoma Cancer Revenue Share by Companies, 2017-2022
Table 8. Global Companies Melanoma Cancer Product Type
Table 9. List of Global Tier 1 Melanoma Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Melanoma Cancer Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Melanoma Cancer Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Melanoma Cancer Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Melanoma Cancer Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Melanoma Cancer Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Melanoma Cancer Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Melanoma Cancer Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Melanoma Cancer Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Melanoma Cancer Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Melanoma Cancer Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Melanoma Cancer Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Melanoma Cancer Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Melanoma Cancer Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Melanoma Cancer Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Melanoma Cancer Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Melanoma Cancer Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Melanoma Cancer Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Melanoma Cancer Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Melanoma Cancer Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Melanoma Cancer Revenue, (US$, Mn), 2023-2028
Table 30. AB Sciences Corporate Summary
Table 31. AB Sciences Melanoma Cancer Product Offerings
Table 32. AB Sciences Melanoma Cancer Revenue (US$, Mn), (2017-2022)
Table 33. Incyte Corporate Summary
Table 34. Incyte Melanoma Cancer Product Offerings
Table 35. Incyte Melanoma Cancer Revenue (US$, Mn), (2017-2022)
Table 36. Merck Corporate Summary
Table 37. Merck Melanoma Cancer Product Offerings
Table 38. Merck Melanoma Cancer Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Melanoma Cancer Product Offerings
Table 41. Novartis Melanoma Cancer Revenue (US$, Mn), (2017-2022)
Table 42. Pierre Fabre Corporate Summary
Table 43. Pierre Fabre Melanoma Cancer Product Offerings
Table 44. Pierre Fabre Melanoma Cancer Revenue (US$, Mn), (2017-2022)
Table 45. Amgen Corporate Summary
Table 46. Amgen Melanoma Cancer Product Offerings
Table 47. Amgen Melanoma Cancer Revenue (US$, Mn), (2017-2022)
Table 48. AstraZeneca Corporate Summary
Table 49. AstraZeneca Melanoma Cancer Product Offerings
Table 50. AstraZeneca Melanoma Cancer Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Melanoma Cancer Product Offerings
Table 53. Bristol-Myers Squibb Melanoma Cancer Revenue (US$, Mn), (2017-2022)
Table 54. Daiichi Sankyo Corporate Summary
Table 55. Daiichi Sankyo Melanoma Cancer Product Offerings
Table 56. Daiichi Sankyo Melanoma Cancer Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Melanoma Cancer Segment by Type in 2021
Figure 2. Melanoma Cancer Segment by Application in 2021
Figure 3. Global Melanoma Cancer Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Melanoma Cancer Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Melanoma Cancer Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Melanoma Cancer Revenue in 2021
Figure 8. By Type - Global Melanoma Cancer Revenue Market Share, 2017-2028
Figure 9. By Application - Global Melanoma Cancer Revenue Market Share, 2017-2028
Figure 10. By Region - Global Melanoma Cancer Revenue Market Share, 2017-2028
Figure 11. By Country - North America Melanoma Cancer Revenue Market Share, 2017-2028
Figure 12. US Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Melanoma Cancer Revenue Market Share, 2017-2028
Figure 16. Germany Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 17. France Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Melanoma Cancer Revenue Market Share, 2017-2028
Figure 24. China Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 28. India Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Melanoma Cancer Revenue Market Share, 2017-2028
Figure 30. Brazil Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Melanoma Cancer Revenue Market Share, 2017-2028
Figure 33. Turkey Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Melanoma Cancer Revenue, (US$, Mn), 2017-2028
Figure 37. AB Sciences Melanoma Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Incyte Melanoma Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merck Melanoma Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Melanoma Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pierre Fabre Melanoma Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Amgen Melanoma Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. AstraZeneca Melanoma Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Melanoma Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Daiichi Sankyo Melanoma Cancer Revenue Year Over Year Growth (US$, Mn) & (2017-2022)